MedTrace Logo

Culturally Enhancing a Motivational Interviewing Intervention For Latinx Adolescents

NCT03947177 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2022-06-30

No results posted yet for this study

Summary

The purpose of this study is to compare two versions of an intervention focused on teaching 10-14-year-old Latina/o adolescent's skills that will decrease the likelihood that they will use tobacco, alcohol, and other drugs. We are also interested in determining how cultural context is related to substance use and whether additional information about other tobacco products should be added to the GMIT intervention.

Conditions

  • Underage Alcohol Use
  • Smoking, Non-Tobacco Products

Interventions

BEHAVIORAL

GMIT

Six 30-minute sessions delivered virtually in a group format. Each week a group facilitator will elicit adolescents' feedback on important topics related to substance use and provide experiential activities to help adolescents explore their beliefs and practice making healthy choices.

BEHAVIORAL

GMIT+

Six 30-minute sessions delivered virtually in a group format. Each week a group facilitator will elicit adolescents' feedback on important topics related to substance use and provide experiential activities to help adolescents explore their beliefs and practice making healthy choices. Parents and/or guardians will virtually participate in parent-only support group sessions.

Sponsors & Collaborators

  • Virginia Foundation of Healthy Youth

    collaborator UNKNOWN

  • Sacred Heart Center

    collaborator UNKNOWN

  • Virginia Polytechnic Institute and State University

    collaborator OTHER

  • William & Mary

    collaborator OTHER

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Rosalie Corona, PhD · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-09
Primary Completion
2021-09-21
Completion
2021-09-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03947177 on ClinicalTrials.gov